Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.68 USD | -9.37% | -0.24% | 0.00% |
Apr. 15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
Apr. 15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.